Item 5.07. Submission of Matters to a Vote of Security Holders.

Shockwave Medical, Inc. (the "Company") held its Annual Meeting of Stockholders on June 24, 2020 (the "Annual Meeting"). Proxies for the Annual Meeting were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended. At the close of business on April 27, 2020, the record date for the Annual Meeting, there were 31,862,235 shares of the Company's common stock, par value $0.001 per share, outstanding and entitled to vote, and 27,416,750 of such shares were voted in person or by proxy at the Annual Meeting on the proposals described below.

At the Annual Meeting, the Company's stockholders voted on the following two proposals, each of which is described in more detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 28, 2020. The number of votes cast with respect to each proposal was as indicated below:

1. Election of Class I Directors. The following nominees were elected to serve as


    Class I directors until the Company's 2023 annual meeting of stockholders and
    until their respective successors are duly elected and qualified, or, if
    sooner, until the director's death, resignation or removal, based on the
    following results of voting:




Nominee                  Votes For    Votes Withheld   Broker Non-Votes
C. Raymond Larkin, Jr.   20,184,098     3,488,389         3,744,263
Laura Francis            20,928,939     2,743,548         3,744,263



2. Ratification of Selection of Independent Registered Public Accounting Firm.


    The selection of Ernst & Young LLP as the independent registered public
    accounting firm for the Company for the fiscal year ending December 31, 2020
    was ratified based on the following results of voting:




Votes For    Votes Against   Abstentions   Broker Non-Votes
27,319,929      26,011         70,810            N/A

© Edgar Online, source Glimpses